(Q28333637)

English

Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension

scientific article (publication date: September 1991)

In more languages

Statements

scholarly article

0 references

Effects of nifedipine GITS and atenolol monotherapy on serum lipids, blood pressure, heart rate, and weight in mild to moderate hypertension (English)

0 references

arterial hypertension

1 reference

based on heuristic

inferred from title

0 references

1 reference

based on heuristic

inferred from title

author name string

M C Houston

1

0 references

L Olafsson

2

0 references

M C Burger

3

0 references

language of work or name

0 references

publication date

September 1991

0 references

0 references

42

0 references

9

0 references

681-90

0 references

Alterations in canine myocardial excitability during ischemia

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

A primary preventive study of Gothenburg, Sweden.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Thiazides, beta blockers and lipoproteins

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Increase in serum-lipids during treatment of hypertension with chlorthalidone

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effect of chronic administration of propranolol on lipoprotein composition

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The effects of antihypertensive drugs on serum lipids and lipoproteins. II. Non-diuretic drugs

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Metabolic consequences of atenolol and propranolol in treatment of essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of two antihypertensive agents on lipids, lipoproteins, and apoproteins A and B. Comparison of prazosin and atenolol

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Antiatherogenic properties of calcium antagonists. State of the art.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effects of diltiazem on serum lipids, exercise performance and blood pressure: randomized, double-blind, placebo-controlled evaluation for systemic hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Long-term results with verapamil in essential hypertension and its influence on serum lipids.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Perspectives on systolic hypertension. The Framingham study.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Multiple effects of calcium entry blockers on renal function in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Effect of nifedipine on renal function in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Epidemiology of coronary heart disease: the Framingham study.

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The Tromsø Heart Study: Serum apolipoprotein Al concentration in relation to future coronary heart disease

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

The relation of apolipoproteins A-I and B in children to parental myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F000331979104200901

21 January 2018

Identifiers

10.1177/000331979104200901

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28333637&oldid=1518850006"